Lilly Eli & Co (NYSE:LLY) Stock Price Up as Sentiment Improves

Eli Lilly and Company (NYSE:LLY) Logo

Sentiment for Lilly Eli & Co (NYSE:LLY)

Lilly Eli & Co (NYSE:LLY) institutional sentiment increased to 0.71 in Q2 2019. Its up 0.05, from 0.66 in 2019Q1. The ratio is more positive, as 386 investment professionals opened new and increased positions, while 540 sold and decreased their positions in Lilly Eli & Co. The investment professionals in our partner’s database now possess: 723.52 million shares, down from 752.92 million shares in 2019Q1. Also, the number of investment professionals holding Lilly Eli & Co in their top 10 positions decreased from 27 to 19 for a decrease of 8. Sold All: 81 Reduced: 459 Increased: 284 New Position: 102.

Eli Lilly and Company discovers, develops, makes, and markets pharmaceutical products worldwide. The company has market cap of $107.04 billion. It operates through two divisions, Human Pharmaceutical Products and Animal Health Products. It has a 13.99 P/E ratio. The firm offers endocrinology products to treat diabetes; osteoporosis in postmenopausal women and men; human growth hormone deficiency and pediatric growth conditions; and testosterone deficiency.

The stock decreased 0.54% or $0.6 during the last trading session, reaching $110.87. About 2.27 million shares traded. Eli Lilly and Company (NYSE:LLY) has risen 11.15% since September 13, 2018 and is uptrending. It has outperformed by 11.15% the S&P500.

Analysts await Eli Lilly and Company (NYSE:LLY) to report earnings on November, 5. They expect $1.43 earnings per share, up 2.88 % or $0.04 from last year’s $1.39 per share. LLY’s profit will be $1.38B for 19.38 P/E if the $1.43 EPS becomes a reality. After $1.50 actual earnings per share reported by Eli Lilly and Company for the previous quarter, Wall Street now forecasts -4.67 % negative EPS growth.

Lilly Endowment Inc holds 100% of its portfolio in Eli Lilly and Company for 116.81 million shares. Private Capital Advisors Inc. owns 285,549 shares or 8.95% of their US portfolio. Moreover, Weatherly Asset Management L. P. has 7.22% invested in the company for 327,170 shares. The Indiana-based Old National Bancorp In has invested 3.79% in the stock. Chesapeake Asset Management Llc, a New York-based fund reported 20,290 shares.

Since January 1, 0001, it had 2 insider buys, and 1 sale for $26.87 million activity.

Eli Lilly and Company (NYSE:LLY) Ratings Coverage

Ratings analysis reveals 60% of Eli Lilly & Co’s analysts are positive. Out of 5 Wall Street analysts rating Eli Lilly & Co, 3 give it “Buy”, 0 “Sell” rating, while 2 recommend “Hold”. The lowest target is $12000 while the high is $140. The stock’s average target of $129.80 is 17.07% above today’s ($110.87) share price. LLY was included in 11 notes of analysts from March 20, 2019. The stock has “Buy” rating by BMO Capital Markets on Thursday, March 21. Bank of America maintained Eli Lilly and Company (NYSE:LLY) on Thursday, March 21 with “Hold” rating. Bank of America maintained Eli Lilly and Company (NYSE:LLY) rating on Tuesday, September 10. Bank of America has “Neutral” rating and $12000 target. As per Wednesday, May 1, the company rating was maintained by BMO Capital Markets. The rating was maintained by Credit Suisse on Friday, March 22 with “Hold”. UBS initiated Eli Lilly and Company (NYSE:LLY) rating on Wednesday, March 20. UBS has “Buy” rating and $140 target.

More notable recent Eli Lilly and Company (NYSE:LLY) news were published by: which released: “Gilead Tops List of Most Innovative Drug Companies – Yahoo Finance” on September 12, 2019, also with their article: “Better Buy: Eli Lilly vs. GlaxoSmithKline – Yahoo Finance” published on August 18, 2019, published: “Eli Lilly & Co. (LLY) Reports FDA Approval for Taltz (ixekizumab) –” on August 26, 2019. More interesting news about Eli Lilly and Company (NYSE:LLY) were released by: and their article: “What Should Investors Know About Eli Lilly and Company’s (NYSE:LLY) Growth? – Yahoo Finance” published on August 01, 2019 as well as‘s news article titled: “Eli Lilly Q1 Earnings Preview – Seeking Alpha” with publication date: April 29, 2019.

Eli Lilly and Company (NYSE:LLY) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.